CCS, a leading provider of clinical solutions and home-delivered medical supplies for those living with chronic conditions, announced it has become the first chronic care management organisation to deploy agentic AI in a comprehensive way across its enterprise operations. Investment in these advanced tools helps streamline the patient experience, particularly during challenging times when an individual may be facing insurance changes, benefit shifts, and/or manufacturer inventory shortages.
Unlike what we are seeing across the industry — where reality has not yet caught up with the AI euphoria, as most AI implementations are still at pilot-scale — CCS has already designed, developed, and deployed a comprehensive and enterprise-wide agentic AI platform. This platform better serves complex patients at scale with measurable positive impact, including savings of more than 30% in annual operating costs.
“CCS is demonstrating an innovative approach to AI in healthcare,” said Bill Fera, MD, GenAI Health and Life Sciences Lead at Deloitte. “By deploying a sophisticated multi-agent network across its entire operation, CCS is transforming how patients with complex care needs are supported in its business — autonomously handling interactions, accelerating care delivery, and improving operational efficiency.”
CeeCee Delivering Immediate Chronic Care Impact
CeeCee — CCS’s agentic AI solution — represents a fundamentally different approach to healthcare AI adoption. Unlike many current AI models, CeeCee is trained on CCS’s own proprietary knowledge and data to deliver empathetic, personalised support that resonates with the chronic care population the company serves.
The platform is projected to autonomously contain 25 per cent of relevant incoming calls in the initial four months, while reducing call handling times across all interactions — resulting in improved patient experience while supporting the real-time needs of frontline teams. In addition to CeeCee, the broader enterprise AI platform from CCS also includes:
Autonomous Documentation Gap Closure – CCS’s AI platform works behind the scenes with healthcare provider offices to autonomously identify and close documentation gaps that delay referrals or reorders for patients waiting for continuous glucose monitor (CGM) or insulin pump supplies. By the end of 2026, this capability is expected to automatically process 70 per cent–80 per cent of the more than 100,000 monthly intake documents, accelerating order fulfilment and getting patients on therapy weeks sooner.
Real-Time Intelligence for Complex Cases – When patient needs exceed CCS’s autonomous capabilities, the AI instantly surfaces consolidated patient profiles, call history, and clinical context for human agents — eliminating the need to navigate across disconnected systems. This consolidation reduces average customer service call handle time by up to 20 per cent, enabling care teams to focus exclusively on complex patient needs rather than juggling back-end administrative work.
“CCS’s platform shows how AI can deliver tangible results at scale today. This is a new level of integration and patient-centric design that is rare — even amid rapid AI advancements happening today, especially in healthcare,” said Jean-Claude Saghbini, President at Lumeris Technology Solutions and technology advisor for CCS.
